276
Views
18
CrossRef citations to date
0
Altmetric
Reviews

A review on the efficacy and safety of iodine-125 seed implantation in unresectable pancreatic cancers

, , , , , & show all
Pages 383-389 | Received 30 Jul 2019, Accepted 13 Nov 2019, Published online: 24 Jan 2020

References

  • Amrutkar M, Gladhaug IP. 2017. Pancreatic cancer chemoresistance to gemcitabine. Cancers (Basel). 9(12):157.
  • Chen JB, Li JL, He LH, et al. 2012. Radical treatment of stage IV pancreatic cancer by the combination of cryosurgery and iodine-125 seed implantation. World J Gastroenterol. 18(47):7056–7062.
  • D'Angio G, Hilaris BS, Arthur K, Murphy JM, Fischer HJ. 1970. Iodine 125 implantation for unresectable cancer of the pancreas. Postgrad Med. 47(3):226–230.
  • Furuse J, Shibahara J, Sugiyama M. 2018. Development of chemotherapy and significance of conversion surgery after chemotherapy in unresectable pancreatic cancer. J Hepatobiliary Pancreat Sci. 25(5):261–268.
  • Gai B, Zhang F. 2018. Chinese expert consensus on radioactive 125I seeds interstitial implantation brachytherapy for pancreatic cancer. J Can Res Ther. 14(7):1455–1462.
  • Goertz SR, Ali MM, Parker GA. 1990. Local management of pancreatic carcinoma: iodine-125 implantation. Clin Oncol (R Coll Radiol). 2(1):22–26.
  • Handley WS. 1934. Pancreatic cancer and the treatment by implanted radium. Ann Surg. 100(1):215–222.
  • He L, Niu L, Korpan NN, Sumida S, Xiao Y, Li J, Sutedja B, Lu Y, Zuo J, Liu J, et al. 2017. Clinical practice guidelines for cryosurgery of pancreatic cancer: a consensus statement from the china cooperative group of cryosurgery on pancreatic cancer, international society of cryosurgery, and asian society of cryosurgery. Pancreas. 46(8):967–972.
  • Hertzanu Y, Ye X. 2018. A valuable guideline of radioactive 125I seeds interstitial implantation brachytherapy for pancreatic cancer. J Can Res Ther. 14(7):1453–1454.
  • Hilaris B, Rousiss K. 1975. Cancer of the pancreas. In: Hilaris BS, editior. Handbook of interstitial brachytherapy. Acton (MA): Publishing Sciences Group (PSG); p. 251–262.
  • Holm HH, Strøyer I, Hansen H, Stadil F. 1981. Ultrasonically guided percutaneous interstitial implantation of iodine 125 seeds in cancer therapy. Br J Radiol. 54(644):665–670.
  • Hu Y, Qi E, Liu F, Lu Y, Tan S, Sun Y, Han Z, Liang P, Yu X. 2018. The application of a three-dimensional visualized seed planning and navigation system in 125I seed implantation for pancreatic cancer. Onco Targets Ther. 11:619–627.
  • Ilic M, Ilic I. 2016. Epidemiology of pancreatic cancer. World J Oncol. 22(44):9694–9705.
  • Isla AM, Worthington T, Kakkar AK, Williamson RC. 2000. A continuing role for surgical bypass in the palliative treatment of pancreatic carcinoma. Dig Surg. 17(2):143–146.
  • Jin Z, Du Y, Li Z, Jiang Y, Chen J, Liu Y. 2008. Endoscopic ultrasonography-guided interstitial implantation of iodine 125-seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma: a prospective pilot study. Endoscopy. 40(04):314–320.
  • Joyce F, Burcharth F, Holm HH, Strøyer I. 1990. Ultrasonically guided percutaneous implantation of iodine-125 seeds in pancreatic carcinoma. Int J Radiat Oncol Biol Phys. 19(4):1049–1052.
  • Kamisawa T, Wood LD, Itoi T, Takaori K. 2016. Pancreatic cancer. Lancet. 388(10039):73–85.
  • Katyal S, Oliver J H, Peterson M S, Ferris J V, Carr B S, Baron R L. 2000. Extrahepatic metastases of hepatocellular carcinoma. Radiology. 216(3):698–703.
  • Kuroda T, Kumagi T, Yokota T, Azemoto N, Hasebe A, Seike H, Nishiyama M, Inada N, Shibata N, Miyata H, et al. 2017. Ehime Pancreato-Cholangiology (EPOCH) Study Group. Efficacy of chemotherapy in elderly patients with unresectable pancreatic cancer: a multicenter review of 895 patients. BMC Gastroenterol. 17(1):66.
  • Le Pimpec Barthes F, Chapuis O, Riquet M, Cuttat JF, Peillon C, Mouroux J, Jancovici R. 1998. Thoracoscopic splanchnicectomy for control of intractable pain in pancreatic cancer. Ann Thorac Surg. 65(3):810–813.
  • Li D, Jia YM, Cao PK, Wang W, Liu B, Li YL. 2018. Combined effect of 125I and gemcitabine on PANC-1 cells: cellular apoptosis and cell cycle arrest. J Can Res Ther. 14(7):1476–1481.
  • Li Q, Tian Y, Yang D, Liang Y, Cheng X, Gai B. 2019. Permanent iodine-125 seed implantation for the treatment of nonresectable retroperitoneal malignant tumors. Technol Cancer Res Treat. 18:153303381982584.
  • Liang D, Shi S, Xu J, Zhang B, Qin Y, Ji S, Xu W, Liu J, Liu L, Liu C, et al. 2016. New insights into perineural invasion of pancreatic cancer: More than pain. Biochim Biophys Acta. 1865(2):111–122.
  • Liu K, Ji B, Zhang W, Liu S, Wang Y, Liu Y. 2014. Comparison of iodine-125 seed implantation and pancreaticoduodenectomy in the treatment of pancreatic cancer. Int J Med Sci. 11(9):893–896.
  • Liu Y, Liu JL, Cai ZZ, Lu Z, Dong YH, Li ZS, Gong YF, Man XH. 2007. A novel approach for treatment of unresectable pancreatic cancer: design of radioactive stents and trial studies on normal pigs. Clin Cancer Res. 13(11):3326–3332.
  • Liu Y, Wang Y, Tang W, Jiang M, Li K, Tao X. 2018. Multiparametric MR imaging detects therapy efficacy of radioactive seeds brachytherapy in pancreatic ductal adenocarcinoma xenografts. Radiol Med. 123(7):481–488.
  • Liu B, Zhou T, Geng J, Zhang F, Wang J, Li Y. 2015. Percutaneous computed tomography-guided iodine-125 seeds implantation for unresectable pancreatic cancer. Indian J Cancer. 52(6):e69–74.
  • Lu Z, Dong TH, Si PR, Shen W, Bi YL, Min M, Chen X, Liu Y. 2016. Continuous Low-dose-rate Irradiation of Iodine-125 seeds inhibiting perineural invasion in pancreatic cancer. Chin Med J (Engl). 129(20):2460–2468.
  • Lv WF, Lu D, Xiao JK, Mukhiya G, Tan ZX, Cheng DL, Zhou CZ, Zhang XM, Zhang ZF, Hou CL. 2017. The side effects and complications of percutaneous iodine-125 seeds implantation under CT-guide for patients with advanced pancreatic cancer. Medicine (Baltimore). 96(52):e9535.
  • Ma JX, Jin ZD, Si PR, Liu Y, Lu Z, Wu HY, Pan X, Wang LW, Gong YF, Gao J, et al. 2011. Continuous and low-energy 125I seed irradiation changes DNA methyltransferases expression patterns and inhibits pancreatic cancer tumor growth. J Exp Clin Cancer Res. 30(1):35.
  • Mohiuddin M, Cantor RJ, Biermann W, Weiss SM, Barbot D, Rosato FE. 1988. Combined modality treatment of localized unresectable adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys. 14(1):79–84.
  • Mohiuddin M, Rosato F, Barbot D, Schuricht A, Biermann W, Cantor R. 1992. Long-term results of combined modality treatment with I-125 implantation for carcinoma of the pancreas. Int J Radiat Oncol Biol Phys. 23(2):305–311.
  • Montes A, Villarroel P, Ayerbes M, Gómez J l C, Aldana G, Tuñas L, Fernández M, Fernández M. 2017. Prognostic and predictive markers of response to treatment in patients with locally advanced unresectable and metastatic pancreatic adenocarcinoma treated with gemcitabine/nab-paclitaxel: Results of a retrospective analysis. J Can Res Ther. 13(2):240–245.
  • Rombouts SJ, Vogel JA, van Santvoort HC, van Lienden KP, van Hillegersberg R, Busch OR, Besselink MG, Molenaar IQ. 2015. Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer. Br J Surg. 102(3):182–193. Epub 2014 Dec 18.
  • Saito S, Ye X. 2017. Expert consensus workshop report: guideline for three-dimensional-printing template-assisted computed tomography-guided 125I seeds interstitial implantation brachytherapy. J Can Res Ther. 13:605–6.
  • Shen Z, Tian L, Wang X. 2018. Treatment of pancreatic head cancer with obstructive jaundice by endoscopy ultrasonography-guided gastrojejunostomy: A case report and literature review. Medicine (Baltimore). 97(28):e11476.
  • Shipley WU, Nardi GL, Cohen AM, Ling CC. 1980. Iodine-125 implant and external beam irradiation in patients with localized pancreatic carcinoma: a comparative study to surgical resection. Cancer. 45(4):709–714.
  • Siegel RL, Miller KD, Jemal A. 2015. Cancer statistics, 2015. CA Cancer J Clin. 65(1):5–29.
  • Syed AM, Puthawala AA, Neblett DL. 1983. Interstitial iodine-125 implant in the management of unresectable pancreatic carcinoma. Cancer. 52(5):808–813.
  • Wang J, Jiang Y, Li J, Tian S, Ran W, Xiu D. 2009a. Intraoperative ultrasound-guided iodine-125 seed implantation for unresectable pancreaticcarcinoma. J Exp Clin Cancer Res. 28(1):88.
  • Wang K, Jin Z, Du Y, Chen J, Zhan X, Wang L, Li Z, Zou D, Liu Y. 2009b. Evaluation of endoscopic-ultrasound-guided celiac ganglion irradiation with iodine-125 seeds: a pilot study in a porcine model. Endoscopy. 41(04):346–351.
  • Wang KX, Jin ZD, Du YQ, Zhan XB, Zou DW, Liu Y, Wang D, Chen J, Xu C, Li ZS. 2012. EUS-guided celiac ganglion irradiation with iodine-125 seeds for pain control in pancreaticcarcinoma: a prospective pilot study. Gastrointest Endosc. 76(5):945–952.
  • Wang ZM, Lu J, Zhang LY, Lin XZ, Chen KM, Chen ZJ, Liu FJ, Yan FH, Teng GJ, Mao AW. 2015. Biological effects of low-dose-rate irradiation of pancreatic carcinoma cells in vitro using 125I seeds. World J Gastroenterol. 21(8):2336–2342.
  • Wang H, Wang J, Jiang Y, Li J, Tian S, Ran W, Xiu D, Gao Y. 2013. The investigation of I-125 seed implantation as a salvage modality for unresectable pancreatic carcinoma. J Exp Clin Cancer Res. 32(1):106.
  • Whittington R, Solin L, Mohiuddin M, Cantor RI, Rosato FE, Biermann WA, Weiss SM, Pajak TF. 1984. Multimodality therapy of localized unresectable pancreatic adenocarcinoma. Cancer. 54(9):1991–1998.
  • Woo SM, Kim MK, Joo J, Yoon KA, Park B, Park SJ, Han SS, Lee JH, Hong EK, Kim YH, et al. 2017. Induction chemotherapy with gemcitabine and cisplatin followed by simultaneous integrated boost-intensity modulated radiotherapy with concurrent gemcitabine for locally advanced unresectable pancreatic cancer: results from a feasibility study. Cancer Res Treat. 49(4):1022–1032.
  • Xiong J, Kwong Chian S, Li J, Liu X. 2017. Iodine-125 seed implantation for synchronous pancreatic metastases from hepatocellular carcinoma: A case report and literature review. Medicine (Baltimore). 96(46):e8726.
  • Xu K, Niu L, Mu F, Hu Y. 2013a. Cryosurgery in combination with brachytherapy of iodine-125 seeds for pancreatic cancer. Gland Surg. 2(2):91–99.
  • Xu W, Liu Y, Lu Z, Jin ZD, Hu YH, Yu JG, Li ZS. 2013b. A new endoscopic ultrasonography image processing method to evaluate the prognosis for pancreatic cancer treated with interstitial brachytherapy. World J Gastroenterol. 19(38):6479–6484.
  • Yu YP, Yu Q, Guo JM, Jiang HT, Di XY, Zhu Y. 2014. Effectiveness and security of CT-guided percutaneous implantation of (125)I seeds in pancreaticcarcinoma. Br J Radiol. 87(1039):20130642.
  • Zheng Z, Xu Y, Zhang S, Pu G, Cui C. 2017. Surgical bypass and permanent iodine-125 seed implantation vs. surgical bypass for the treatment of pancreatic head cancer. Oncol Lett. 14(3):2838–2844.
  • Zhongmin W, Yu L, Fenju L, Kemin C, Gang H. 2010. Clinical efficacy of CT-guided iodine-125 seed implantation therapy in patients with advanced pancreatic cancer. Eur Radiol. 20(7):1786–1791.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.